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Assessing a potential resurgence of an epidemic outbreak with
certainty is as important as it is challenging. The low number of
infectious individuals after a long regression, and the
randomness associated with it, makes it difficult to ascertain
whether the infectious population is growing or just fluctuating.
We have developed an approach to compute confidence
intervals for the switching time from decay to growth and to
compute the corresponding multiple-location aggregated
quantities over a region to increase the precision of the
determination. We estimated the aggregate prevalence over time
for Europe and the northeast United States to characterize the
COVID-19 second surge in these regions during year 2020. We
find a starting date as early as 3 July (95% confidence
interval (CI): 1–6 July) for Europe and 19 August (95% CI: 16–23
August) for the northeast United States; subsequent infectious
populations that, as of 31 December, have always increased or
remained stagnant; and the resurgences being the collective
effect of each overall region with no location, either country or
state, dominating the regional dynamics by itself.1. Introduction
Identifying a potential resurgence of an epidemic outbreak is
crucial to timely implementation of measures for its mitigation
and control. A major challenge, however, is the high uncertainty
present because of the low prevalence values at which it typically








































locations through the ongoing COVID-19 pandemic [1–4]. At the field level, direct characterization
through randomized testing would need large population studies to provide significant results
and using infection case data is dependent on varying testing rates [2,3]. More robust approaches
based on death counts are also affected by the extremely small number of random events on
which they rely for inference [2,4]. This uncertainty in assessing the state of the outbreak for a
potential resurgence is a source of delays in the decision making and intervention implementation
processes.
Here, we address two main computational needs to precisely characterize a resurgence. The first
one is how to establish confidence intervals in the timing of the resurgence. These intervals
range from the time it is certain that the infectious population has stopped decreasing to the time
it is certain that the population has started to increase with a given confidence level. The second
need is how to aggregate different local data into supra-local quantities to identify whether the
resurgence is a collective regional effect and, if so, to determine the initiation of the resurgence
more confidently.
We focus explicitly on Europe and the northeast United States (USA), which have experienced a
second surge of the COVID-19 outbreak after a similar initial outburst and subsequent regression.
None of these resurgences was widely expected nor anticipated [5,6]. Both regions display high
mobility among their locations and broad independence among locations to enact measures to
mitigate the propagation of the outbreak. In the case of Europe, Schengen Area countries allow for
unrestricted border crossings among them. Mobility restrictions, lockdowns and other non-
pharmaceutical interventions were able to achieve a major regression of the outbreaks, but the gradual
lifting of restrictions has resulted in a resurgence across locations in these two regions [2,7]. The
characterization of the similarities and differences of the outbreak progression in these two areas is
needed to provide insights into the effectiveness of the actions taken, to ascertain the extent their
results can be extrapolated from one region to another, and to informedly mitigate the current and
potentially forthcoming resurgences.2. Methods
2.1. Upper and lower bounds of the growth rate determine the confidence interval of the
resurgences




nI(t) ¼ kG(t)nI(t), ð2:1Þ
where kG(t) is its per capita growth rate with upper and lower bounds of the confidence interval (CI)
denoted by kUG (t) and k
L
G(t), respectively.
In epidemiology, it is customary to use the time-varying reproduction number Rt, which describes the
expected number of infections arising from a single case in the population [8,9]. It is related to the growth





where fGT(t) is the probability density function of the generation time [8,9]. We consider the usual










for kG(t) . b and Rt ¼ 0 for kG(t)  b. The values of the parameters are given by a ¼ t2G=s2G and








































The starting date of the second surge, t2, is computed as the date the infectious population reached a
minimum value after the maximum of the first surge at time denoted by t1:
t2 ¼ argmin
t
nI(t) subject to t . t1, ð2:5Þ
which in continuous time corresponds to a zero value of the growth rate (reproduction number equal to
1): kG(t2 ) ≃ 0.
To compute confidence intervals for the switching time from negative to positive growth, we consider
the confidence intervals of the population growth rate. Explicitly, when the upper bound of the growth
rate is negative (reproduction number below 1), we can ascertain that the population is decreasing with a
given confidence level. Analogously, when the lower bound of the growth rate is positive (reproduction
number above 1), we can ascertain that the population is increasing with a given confidence level.
Therefore, the lower bound, tL2 , of the CI of the starting date of the second surge is computed as the
last day before the minimum in which the upper bound of the CI of the growth rate is negative
(reproduction number below 1):
tL2 ¼ maxt t subject to k
U
G (t ) , 0 and t , t2: ð2:6Þ
Analogously, the upper bound, tU2 , of the CI is computed as the first day after reaching the minimum
in which the lower bound of the CI of the growth rate is positive (reproduction number above 1):
tU2 ¼ mint t subject to k
L
G(t ) . 0 and t . t2: ð2:7Þ
Note that, although the accuracy of the approach is dependent on the accuracy of the underlying
characterization of the infectious population, the determination of t2, tL2 , t
U
2 is independent of potential
multiplicative biases in nI(t), kUG (t ) and k
L
G(t ).
The approach is illustrated for Connecticut (northeast USA) and Austria (Europe’s Schengen Area) in
figure 1. The trajectories of the infectious populations, the growth rates, and the 95% confidence intervals
(CI) for each location were downloaded on 21 April 2021, from https://github.com/Covid19Dynamics/
trajectories. The data consider explicitly the age-specific infection fatality rates from Verity et al. [10],
which are consistently similar among distinct locations [11,12], to infer the local infectious population
from reported death counts [4]. Reproduction numbers were computed from the growth rates for each
location by considering a gamma-distributed generation time, independent of the location, with a
mean of 6.5 days and a standard deviation of 4.2 days [13]. The two locations in figure 1 show that,
in general, there is a high uncertainty in the timing that can be attributed to the starting date of the
resurgence.2.2. Aggregate values provide a potential avenue to increase the reliability of the estimates for
low prevalence values





where nI,j(t) is the infectious population of the specific location with index j. Using the method of
variance estimates recovery [14], which parallels the methodology of error propagation, the
corresponding upper and lower confidence intervals are computed as















from the upper, nUI,j(t), and lower, n
L
I,j(t), confidence intervals for each location.
The method of variance estimates recovery cannot be used directly to compute the confidence
intervals for the aggregate growth rate. We derive the expressions for the upper and lower bounds by
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Figure 1. Location-specific characterization of the COVID-19 resurgence. The approach to locate the time of the resurgence and its
confidence intervals is illustrated with data for Connecticut (a,b) and Austria (c,d ). The top panels (a,c) show the temporal evolution
of the infectious population with the shaded blue region indicating the 95% confidence intervals (CI). The bottom panels (b,d ) show
the temporal evolution of the reproduction number (blue line) with the shaded blue region indicating the 95% CI. The dotted lines
highlight the span of the second wave and its CI over the reproduction number data. Black markers indicate the starting date of the
resurgence ðt2Þ and the lower ðtL2Þ and upper ðtU2 Þ bound of its 95% CI. Reproduction numbers were computed from growth rates




























































kG,j(t) nI,j(t) ¼ kG(t)nI(t): ð2:12Þ
The corresponding upper and lower confidence intervals are computed as



















from the upper, kUG,j(t), and lower, k
L
G,j(t), confidence intervals for each location. These expressions
explicitly consider that the uncertainty in the infectious populations times the corresponding growth










































3.1. The second surges started in early-mid summer with the northeast USA trailing Europe
To assess the properties of the resurgences with increased confidence, we computed the aggregate values
of the infectious populations and the corresponding time-varying reproduction numbers for Europe’s
Schengen Area and the northeast USA from the individual values of the locations of each region [4].
We considered overall region values and overall region values excluding one location. Exclusion of
one location provides an avenue to reliably infer the effects of the location in the overall region.
The initial progression of the overall infectious populations for both regions consisted of exponential
growth followed by exponential decay (figure 2a,b). Subsequently, there was a sharp transition to fast
exponential growth in Europe on 3 July (95% CI: 1–6 July), 2020, from an estimated infectious
population of 3.0 × 104 (95% CI: 2.4 × 104–3.5 × 104) individuals and a stagnant overall infectious
population in the northeast USA, which started to grow slowly but with increasing speed on
19 August (95% CI: 16–23 August), 2020, from an estimated infectious population of 3.3 × 104 (95% CI:
2.8 × 104–3.8 × 104) individuals.
3.2. The resurgence has been more abrupt and intense in Europe than in the northeast USA
Concomitantly, the time-varying reproduction numbers crossed above one on the resurgence dates less
abruptly in the northeast USA than in Europe (figure 2c), reaching maximum values of 1.50 (95% CI:
1.48–1.51) in Europe and 1.30 (95% CI: 1.27–1.34) in the northeast USA. The sharp resurgence to
exponential growth in Europe is coincidental with lifting major non-pharmaceutical interventions that
curved the outbreak [15], including the coordinated end of travel bans in Schengen Area’s countries
on 1 July 2020 [16].
No substantial decreases in the overall infectious population, nor corresponding reproduction
numbers below one, were observed for any of the two regions over three months after the starting
dates of the second surges (figure 2). The estimated infectious population just stopped growing in the
northeast USA in late December (figure 2b) and entered a prolonged stagnant state in Europe in early
November (figure 2a).
3.3. Aggregate values are highly reliable compared to location-specific data
The low prevalence at the location-specific level leads to broad confidence intervals for both the
infectious population and the time-varying reproduction numbers, which makes ascertaining the local
growth properties of the outbreak unreliable over prolonged periods of time (figures 1 and 3, and
electronic supplementary material, figure S1). The aggregated values for each region provide precise
evidence of sustained growth of the outbreaks already over the summer, despite the uncertainty and
variability present in each of the locations independently (figure 3 and electronic supplementary
material, figure S1).
Our results also provide robust evidence that the resurgence was not driven by a unique location
since any aggregate value of the starting date for each region leaving one of their locations out is
within the confidence limits of the overall region (figure 3 and electronic supplementary material,
figure S1). Therefore, the resurgences were the collective effect of each overall region.4. Discussion
COVID-19 second surges in Europe and the northeast USA exemplify the difficulties of ascertaining the
presence of an incipient epidemic resurgence and to determine whether the infectious population is
growing or just fluctuating. We have provided an avenue to quantify the uncertainty present and the
methodology to increase the reliability of the assessment by aggregating location-specific data in
regional quantities.
The approach we have developed to quantify the uncertainty in the timing of a resurgence is based on
the confidence intervals of the growth rate (or equivalently, those of the reproduction number) to
ascertain, with a given confidence level, that the population is decreasing when the upper bound of
the growth rate is negative and increasing when the lower bound of the growth rate is positive. The
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Figure 2. Temporal evolution of the COVID-19 outbreak in Europe and the northeast USA. Progression over time of the infectious
population for countries in Europe’s Schengen Area (a) and locations in the northeast USA (b) and of their corresponding
reproduction numbers (c). Each coloured section in the area plots represents the contribution of a country (a) or state (b) to
the overall infectious populations. Countries and states are arranged in alphabetical order from bottom to top. The infectious
populations are plotted on a logarithmic scale to highlight the triphasic behaviour (growth-decay-growth) of the outbreak. The
shaded regions in the reproduction number plots (c) represent the 95% CI. Locations with fewer than 30 reported COVID-19








































aggregate values and their corresponding confidence intervals for a region, computed from those of its
locations, allowed us to make precise assessments at a regional level. We obtained explicitly that regional
values for the timing of COVID-19 second surges in Europe and the northeast USA are more precise than
those of the individual locations and that the resurgences in these two regions are the collective effect of
each overall region with no location, either country or state, dominating the regional dynamics by itself.
There are multiple behavioural, environmental and urban factors that affect the progression of






























































Figure 3. Timing of the COVID-19 outbreak resurgence in Europe and the Northeast USA. Dates of the minimum infectious
population reached are shown for each location (red crosses) and for the whole region without the population of the location
indicated (blue circles). The intervals represent the 95% CI. Locations with fewer than 30 reported COVID-19 deaths were not








































similar patterns across states in the northeast USA and across countries in Europe’s Schengen Area. Our
results show that indeed the confidence intervals of the timing of the second surge largely overlap among
states and among countries in these two regions.
The northeast USA, as a region, closely trailed Europe in the second surge of the outbreak, but with a
markedly smaller growth and evidence of slowing down earlier in the growth phase than Europe. Key
differences in the actions taken included more gradual lifting and swifter progressive reimplementation
of measures in the northeast USA than in Europe [15]. Our results show, through the progression over
time of the aggregate prevalence of Europe’s Schengen Area countries, with high certainty, that
Europe’s initial acting upon the second surge in mid-late October [5] took place well after a three-
month-long period of sustained growth of the COVID-19 infectious population in the overall region,






































reimplementation of measures, such a high death toll has not been reached in the northeast USA [15].
Therefore, our results highlight the need to implement policies and surveillance approaches that also
include data at a supra-location level when there is high mobility among locations.
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